Citius Oncology (CTOR) Cash from Financing Activities (2023 - 2026)
Citius Oncology's (CTOR) quarterly Cash from Financing Activities came in at -$231199.0 in Q1 2026, down 101.53% on a QoQ basis from $15.1 million in Q4 2025.
Citius Oncology (CTOR) Cash from Financing Activities (2023 - 2026) Analysis & Trends
Citius Oncology (CTOR) has 4 years of Cash from Financing Activities data on file, last reported at -$231199.0 in Q1 2026.
- On a quarterly basis, Cash from Financing Activities changed N/A year-over-year to -$231199.0 in Q1 2026; TTM through Mar 2026 was -$9.4 million, a N/A change from a year earlier, with the FY2025 full-year figure at $15.2 million, up 211.19% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at -$231199.0, down from $15.1 million in the prior quarter.
- Over the last five years, Cash from Financing Activities for CTOR reached as high as $15.1 million in Q4 2025 and fell as low as -$24.5 million in Q1 2024.
- Historically, Cash from Financing Activities has averaged -$1.7 million across 4 years, with a median of $264393.0 in 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -840.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -494.13 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -1.48 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -203.80 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -86.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -65.00 Mn |
| 10 | Citius Oncology | 58.02 Mn | 58.02 Mn | 1.34 Mn | -231,199.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -231,199.00 |
| Mar 31, 2026 | -231,199.00 |
| Dec 31, 2025 | 15.13 Mn |
| Dec 31, 2025 | 15.13 Mn |
| Jun 30, 2024 | 264,393.00 |
| Jun 30, 2024 | 264,393.00 |
| Mar 31, 2024 | -24.55 Mn |
| Mar 31, 2024 | -24.55 Mn |
| Sep 30, 2023 | 779,875.00 |
| Sep 30, 2023 | 779,875.00 |